Clinical trial efficiency RxSolutions offers the innovative Rx Study Card which streamlines supply management for clinical trials by enabling subjects to pick up unblinded medications and supplies at local pharmacies, reducing forecasting, sourcing, storing, and logistics costs. This presents a strong upsell opportunity to pharmaceutical manufacturers and trial sponsors seeking to accelerate study timelines and cut operational overhead.

Copay program value Their traditional copay and discount programs can help pharma brands grow and retain patients, boost product revenue streams, and improve adherence. This creates cross-sell potential to existing pharma marketers looking to enhance patient engagement, loyalty, and market share across multiple products.

Data driven partnerships RxSolutions emphasizes collaborative, data-driven program design. This approach is attractive to senior decision makers pursuing measurable ROI, allowing sales to position RxSolutions as a strategic partner capable of tailoring campaigns to goals, opportunities, and challenges facing clinical trials and patient accessibility.

Private, niche, US footprint A North Carolina‑based, privately held firm with over 20 years of experience and clients across the United States suggests reliability and deep domain knowledge. This can be leveraged to target mid‑sized pharma companies seeking specialized, compliant patient access and trial support services at a favorable value proposition.

Growth and maturity signals With a revenue range of one to ten million and a history of acquisition by TrialCard, RxSolutions is positioned as a scalable partner transitioning from niche operations to broader market integration. This indicates opportunities for upsell into larger product suites and partnerships as the company expands.